The levels of plasma MPO-DNA, nucleosomes, and DNA were significantly elevated in patients with more severe CAD, and could predict the number of diseased coronary artery segments and the incidence of major adverse cardiac events (MACE). The gene discussed is MPO; the disease is coronary artery disorder.